Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (238)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
12
2025
528
1.220
 Why?
Germ-Line Mutation
9
2013
66
1.020
 Why?
Hamartoma Syndrome, Multiple
8
2012
15
1.020
 Why?
PTEN Phosphohydrolase
13
2015
55
0.990
 Why?
Barrett Esophagus
2
2019
31
0.960
 Why?
Esophageal Neoplasms
2
2019
111
0.870
 Why?
Adenocarcinoma
3
2019
404
0.790
 Why?
Haplotypes
3
2020
94
0.740
 Why?
Homozygote
3
2019
58
0.630
 Why?
Polymorphism, Single Nucleotide
9
2021
506
0.630
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
169
0.600
 Why?
Proto-Oncogene Proteins c-akt
4
2012
172
0.560
 Why?
Databases, Factual
1
2020
715
0.530
 Why?
Capacity Building
2
2025
26
0.440
 Why?
Alleles
6
2021
278
0.430
 Why?
Smoke-Free Policy
2
2025
15
0.430
 Why?
Lung Neoplasms
3
2020
634
0.420
 Why?
Phosphatidylinositol 3-Kinases
2
2012
150
0.390
 Why?
Genotype
6
2021
571
0.380
 Why?
Scavenger Receptors, Class A
1
2011
39
0.360
 Why?
Extracellular Matrix Proteins
1
2011
69
0.360
 Why?
Case-Control Studies
5
2025
1202
0.300
 Why?
Humans
39
2025
52593
0.290
 Why?
Transcription Factors
1
2011
566
0.280
 Why?
Genetic Variation
3
2021
230
0.280
 Why?
Breast Neoplasms
7
2017
1205
0.280
 Why?
Thyroid Neoplasms
4
2012
116
0.270
 Why?
Heart Defects, Congenital
2
2024
622
0.260
 Why?
Tobacco Smoke Pollution
2
2025
55
0.250
 Why?
Limb Deformities, Congenital
1
2025
15
0.240
 Why?
Genes, Wilms Tumor
1
2005
1
0.240
 Why?
Population
1
2005
8
0.240
 Why?
Gene Frequency
3
2020
99
0.230
 Why?
Social Justice
1
2025
33
0.230
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
20
0.230
 Why?
Genome
2
2019
62
0.230
 Why?
Female
23
2025
28262
0.220
 Why?
Evidence-Based Practice
1
2025
111
0.220
 Why?
Lamin Type A
1
2024
6
0.220
 Why?
Adult
17
2025
14170
0.220
 Why?
Middle Aged
17
2025
13096
0.220
 Why?
Exome
2
2025
55
0.210
 Why?
Linkage Disequilibrium
2
2020
40
0.200
 Why?
Male
16
2025
26863
0.180
 Why?
DNA Methylation
2
2024
592
0.180
 Why?
Inheritance Patterns
1
2021
22
0.180
 Why?
Phenotype
7
2021
800
0.170
 Why?
Models, Genetic
5
2013
172
0.170
 Why?
Risk Factors
5
2019
3952
0.170
 Why?
Succinate Dehydrogenase
2
2011
22
0.170
 Why?
Stilbenes
2
2010
58
0.170
 Why?
Fires
1
2020
15
0.160
 Why?
Agriculture
1
2020
18
0.160
 Why?
Aged
11
2020
10191
0.160
 Why?
Tobacco Products
1
2021
127
0.160
 Why?
Cluster Analysis
4
2013
233
0.160
 Why?
Social Media
1
2021
117
0.160
 Why?
Aged, 80 and over
5
2020
3420
0.150
 Why?
Arkansas
5
2025
2029
0.150
 Why?
Genomics
1
2020
270
0.150
 Why?
Cell Proliferation
3
2010
1029
0.140
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
146
0.140
 Why?
Prostatic Neoplasms
2
2012
400
0.140
 Why?
Gene Expression Regulation, Neoplastic
3
2010
857
0.130
 Why?
Young Adult
8
2025
4337
0.130
 Why?
Prognosis
2
2020
2118
0.130
 Why?
Endometrial Neoplasms
2
2015
144
0.130
 Why?
Leprosy
1
2016
8
0.130
 Why?
Hypertension
1
2021
570
0.120
 Why?
Emergency Service, Hospital
1
2020
524
0.120
 Why?
Asthma
1
2020
317
0.120
 Why?
Microsatellite Repeats
2
2012
42
0.120
 Why?
Regression Analysis
2
2017
403
0.120
 Why?
Smoking
2
2025
518
0.120
 Why?
Aromatase
1
2015
8
0.120
 Why?
Tuberculosis
1
2016
152
0.110
 Why?
Genetic Linkage
2
2011
25
0.110
 Why?
Sirolimus
2
2010
72
0.100
 Why?
Adolescent
8
2021
6737
0.100
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
3
0.100
 Why?
Genome-Wide Association Study
2
2012
187
0.100
 Why?
Smad4 Protein
1
2013
6
0.100
 Why?
Genetic Testing
2
2010
130
0.100
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.100
 Why?
Cohort Studies
3
2012
1553
0.100
 Why?
Colonic Polyps
1
2013
39
0.100
 Why?
Receptors, Cell Surface
1
2013
113
0.100
 Why?
Mitochondrial Diseases
1
2012
45
0.090
 Why?
Codon, Nonsense
1
2012
28
0.090
 Why?
Flavin-Adenine Dinucleotide
1
2011
4
0.090
 Why?
Antigens, CD
1
2013
216
0.090
 Why?
NAD
1
2011
45
0.090
 Why?
Genes, p53
1
2011
52
0.090
 Why?
DNA, Neoplasm
1
2012
146
0.090
 Why?
Mutation, Missense
1
2012
108
0.090
 Why?
Siblings
1
2011
34
0.090
 Why?
Taxoids
1
2011
38
0.090
 Why?
Adenoma
1
2012
113
0.090
 Why?
Risk
1
2012
313
0.090
 Why?
Gene Expression Profiling
3
2012
1110
0.090
 Why?
Software
1
2013
280
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Receptors, Androgen
1
2010
47
0.080
 Why?
Cephalometry
1
2010
18
0.080
 Why?
Colorectal Neoplasms
2
2012
295
0.080
 Why?
Tumor Microenvironment
1
2012
255
0.080
 Why?
Head
1
2010
70
0.080
 Why?
Gene Dosage
1
2009
78
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
54
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
137
0.080
 Why?
Patient Selection
1
2010
266
0.080
 Why?
Cell Communication
1
2009
72
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
327
0.070
 Why?
Age Factors
1
2012
1132
0.070
 Why?
Immunohistochemistry
1
2011
984
0.070
 Why?
Urinary Bladder Neoplasms
1
2010
165
0.070
 Why?
United States
3
2025
5227
0.070
 Why?
Chromosome Mapping
2
2021
151
0.070
 Why?
Prevalence
2
2021
1017
0.070
 Why?
Prospective Studies
4
2017
2457
0.070
 Why?
Mass Screening
1
2010
358
0.070
 Why?
Rural Population
2
2022
572
0.060
 Why?
Cell Line, Tumor
4
2011
1436
0.060
 Why?
Physical Chromosome Mapping
1
2005
7
0.060
 Why?
Antineoplastic Agents
2
2011
1221
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
2
0.060
 Why?
DNA Copy Number Variations
1
2025
117
0.060
 Why?
Exons
1
2005
101
0.060
 Why?
Counseling
1
2025
137
0.060
 Why?
Child
5
2020
7229
0.050
 Why?
CpG Islands
1
2024
121
0.050
 Why?
Models, Theoretical
1
2005
182
0.050
 Why?
Gene Expression Regulation
1
2008
1006
0.050
 Why?
Mutation
2
2010
1344
0.050
 Why?
Biopsy
1
2005
607
0.050
 Why?
Polyproteins
1
2022
3
0.050
 Why?
Smoking Cessation
1
2025
315
0.050
 Why?
Child, Preschool
3
2020
4062
0.050
 Why?
RNA, Viral
1
2022
125
0.050
 Why?
Risk Assessment
2
2021
1350
0.050
 Why?
Phosphoproteins
1
2022
122
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
6
0.040
 Why?
United States Food and Drug Administration
1
2021
96
0.040
 Why?
Membrane Glycoproteins
1
2022
242
0.040
 Why?
Nutrition Surveys
1
2021
117
0.040
 Why?
Loss of Heterozygosity
2
2012
78
0.040
 Why?
Stromal Cells
2
2012
77
0.040
 Why?
Nicotine
1
2021
176
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
82
0.040
 Why?
Self Report
1
2021
215
0.040
 Why?
Pedigree
2
2010
126
0.040
 Why?
Seasons
1
2020
91
0.040
 Why?
Odds Ratio
1
2021
568
0.040
 Why?
Air Pollution
1
2020
49
0.040
 Why?
Neoplasms
1
2009
1308
0.040
 Why?
Phosphorylation
2
2010
530
0.040
 Why?
Signal Transduction
3
2010
1714
0.040
 Why?
Gene Expression
2
2012
623
0.040
 Why?
Sensitivity and Specificity
2
2012
883
0.040
 Why?
Predictive Value of Tests
2
2012
952
0.040
 Why?
Infant
2
2020
3720
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
1378
0.030
 Why?
Angiopoietin-2
1
2017
14
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
87
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
187
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
Cross-Sectional Studies
1
2021
1686
0.030
 Why?
Neoadjuvant Therapy
1
2017
125
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
54
0.030
 Why?
Pilot Projects
1
2016
721
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
83
0.020
 Why?
Genome, Human
1
2013
121
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Penetrance
1
2012
7
0.020
 Why?
Neoplasm Grading
1
2012
126
0.020
 Why?
Genetic Association Studies
1
2012
124
0.020
 Why?
Vincristine
1
2011
88
0.020
 Why?
Anthracyclines
1
2011
31
0.020
 Why?
Inhibitory Concentration 50
1
2010
74
0.020
 Why?
Paclitaxel
1
2011
91
0.020
 Why?
Formazans
1
2010
4
0.020
 Why?
Tetrazolium Salts
1
2010
15
0.020
 Why?
Immunoblotting
1
2010
119
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.020
 Why?
Drug Synergism
1
2010
148
0.020
 Why?
HEK293 Cells
1
2011
232
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
155
0.020
 Why?
Michigan
1
2010
26
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
 Why?
Epithelial Cells
1
2012
215
0.020
 Why?
Point Mutation
1
2010
69
0.020
 Why?
Neoplasm Transplantation
1
2010
86
0.020
 Why?
Androgens
1
2010
70
0.020
 Why?
Kidney Neoplasms
1
2012
181
0.020
 Why?
Adenosine Triphosphate
1
2011
209
0.020
 Why?
Transplantation, Heterologous
1
2010
78
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
BRCA2 Protein
1
2009
19
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
76
0.020
 Why?
Comparative Genomic Hybridization
1
2009
39
0.020
 Why?
Polymerase Chain Reaction
1
2011
460
0.020
 Why?
BRCA1 Protein
1
2009
35
0.020
 Why?
Mice, Nude
1
2010
235
0.020
 Why?
Proteins
1
2012
354
0.020
 Why?
Chi-Square Distribution
1
2010
295
0.020
 Why?
Cell Cycle
1
2010
240
0.020
 Why?
Protein Binding
1
2011
673
0.020
 Why?
Gene Deletion
1
2010
275
0.020
 Why?
Algorithms
1
2013
668
0.020
 Why?
Diagnosis, Differential
1
2012
1048
0.020
 Why?
Cell Survival
1
2010
602
0.020
 Why?
Neoplastic Stem Cells
1
2009
93
0.020
 Why?
Neoplasm Invasiveness
1
2009
278
0.020
 Why?
Promoter Regions, Genetic
1
2010
474
0.020
 Why?
Incidence
1
2012
1077
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
184
0.020
 Why?
Membrane Proteins
1
2010
337
0.020
 Why?
Neoplasm Staging
1
2011
768
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
412
0.020
 Why?
Microscopy, Confocal
1
2008
82
0.020
 Why?
Cell Differentiation
1
2011
673
0.020
 Why?
Chromosome Aberrations
1
2009
297
0.020
 Why?
Survival Rate
1
2010
952
0.020
 Why?
Registries
1
2010
629
0.020
 Why?
Treatment Outcome
1
2017
5486
0.020
 Why?
Chromosomes, Human
1
2005
41
0.020
 Why?
Time Factors
1
2010
3000
0.010
 Why?
Reproducibility of Results
1
2005
1217
0.010
 Why?
Mice
1
2010
5958
0.010
 Why?
Animals
1
2010
13507
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (238) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department